Anti-MSI2 monoclonal antibody

Pre-made anti-MSI2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MSI2/MSI2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T35817-Ab-1/ GM-Tg-hg-T35817-Ab-2Anti-Human MSI2 monoclonal antibodyHuman
GM-Tg-rg-T35817-Ab-1/ GM-Tg-rg-T35817-Ab-2Anti-Rat MSI2 monoclonal antibodyRat
GM-Tg-mg-T35817-Ab-1/ GM-Tg-mg-T35817-Ab-2Anti-Mouse MSI2 monoclonal antibodyMouse
GM-Tg-cynog-T35817-Ab-1/ GM-Tg-cynog-T35817-Ab-2Anti-Cynomolgus/ Rhesus macaque MSI2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T35817-Ab-1/ GM-Tg-felg-T35817-Ab-2Anti-Feline MSI2 monoclonal antibodyFeline
GM-Tg-cang-T35817-Ab-1/ GM-Tg-cang-T35817-Ab-2Anti-Canine MSI2 monoclonal antibodyCanine
GM-Tg-bovg-T35817-Ab-1/ GM-Tg-bovg-T35817-Ab-2Anti-Bovine MSI2 monoclonal antibodyBovine
GM-Tg-equg-T35817-Ab-1/ GM-Tg-equg-T35817-Ab-2Anti-Equine MSI2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T35817-Ab-1/ GM-Tg-hg-T35817-Ab-2; GM-Tg-rg-T35817-Ab-1/ GM-Tg-rg-T35817-Ab-2;
GM-Tg-mg-T35817-Ab-1/ GM-Tg-mg-T35817-Ab-2; GM-Tg-cynog-T35817-Ab-1/ GM-Tg-cynog-T35817-Ab-2;
GM-Tg-felg-T35817-Ab-1/ GM-Tg-felg-T35817-Ab-2; GM-Tg-cang-T35817-Ab-1/ GM-Tg-cang-T35817-Ab-2;
GM-Tg-bovg-T35817-Ab-1/ GM-Tg-bovg-T35817-Ab-2; GM-Tg-equg-T35817-Ab-1/ GM-Tg-equg-T35817-Ab-2
Products NameAnti-MSI2 monoclonal antibody
Formatmab
Target NameMSI2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MSI2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T35817-Ag-1Recombinant multi-species MSI2H/ MSI2 protein
    ORF Viral VectorvGMAP000181Human MSI2 Adenovirus particle
    ORF Viral VectorpGMLV000033human MSI2 Lentivirus plasmid
    ORF Viral VectorvGMLV000033human MSI2 Lentivirus particle
    ORF Viral VectorpGMAP000181Human MSI2 Adenovirus plasmid
    ORF Viral VectorpGMLPm001424mouse Msi2 Lentivirus plasmid
    ORF Viral VectorvGMLPm001424mouse Msi2 Lentivirus particle


    Target information

    Target IDGM-T35817
    Target NameMSI2
    Gene ID124540,76626,360596,100423536,475148,101084147,505542,100070744
    Gene Symbol and Synonyms1700105C15Rik,MSI2,MSI2H,RGD1560397
    Uniprot AccessionQ96DH6
    Uniprot Entry NameMSI2H_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000153944
    Target ClassificationTumor-associated antigen (TAA)

    The target: MSI2, gene name: MSI2, also named as MSI2H. This gene encodes an RNA-binding protein that is a member of the Musashi protein family. The encoded protein is transcriptional regulator that targets genes involved in development and cell cycle regulation. Mutations in this gene are associated with poor prognosis in certain types of cancers. This gene has also been shown to be rearranged in certain cancer cells. [provided by RefSeq, Apr 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.